Tuesday, November 25, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

SELLAS Life Sciences Group Faces Stock Decline After Announcing Registered Direct Offering and Private Placement

Elaine Mendonca by Elaine Mendonca
March 15, 2024
in Breaking News
0
Biotechnology Markets and money
0
SHARES
8
VIEWS
Share on FacebookShare on Twitter

SELLAS Life Sciences Group is experiencing a decrease in their stock value after revealing a $20 million registered direct offering and simultaneous private placement of 13,029,316 shares, each priced at $1.535. This development has led to a drop in the stock price of SELLAS Life Sciences Group Inc. (SLS) as investors are concerned about the impact of the increased number of shares on the company’s value.

As of March 15, 2024, the market has reacted negatively to this news, causing a decline in SELLAS Life Sciences Group’s shares.

SLS Stock Price Plummets by 30% on March 15, 2024: What Does it Mean for Investors?

On March 15, 2024, SLS stock experienced a significant drop in price, opening at $1.22, which was $0.33 lower than its previous close. Throughout the day, the stock continued to decline, ending with a price of $0.75, a decrease of $0.47 from the previous close. This represents a 30.00% drop in the stock price.

Investors and analysts may be closely monitoring SLS stock to see if this drop is a temporary dip or a sign of a longer-term trend. Factors such as company performance, industry trends, and market conditions could all be influencing the stock’s performance on this particular day.

SLS Stock Reports Significant Decline in Net Income and EPS Over Past Year and Quarter

On March 15, 2024, SLS stock experienced a decline in its net income compared to the previous year and quarter. The company reported a net income of -$41.30 million over the past year, which represents a significant decrease of 99.53% compared to the previous year. In the most recent quarter, SLS reported a net income of -$9.27 million, showing a decrease of 4.83% compared to the previous quarter.

Similarly, the earnings per share (EPS) of SLS also saw a decline over the past year and quarter. The EPS for the past year was reported at -$2.13, representing a decrease of 59.27% compared to the previous year. In the most recent quarter, the EPS was reported at -$0.33, showing a decrease of 4.81% compared to the previous quarter.

Unfortunately, the total revenue for SLS is currently unavailable, so it is difficult to assess the overall financial performance of the company. However, based on the net income and EPS data provided, it is evident that SLS has experienced a decline in its financial performance over the past year and quarter.

Tags: SLS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finances

Investor Sentiment and Options Activity for Halliburton on March 15 2024

MA stock news

Analyst Reaffirms Neutral Rating on Solo Brands with Adjusted Price Target

CRWD stock news

Verb Technologys Stock Price Skyrockets A Promising Turn of Events

Recommended

Solana Stock

Solana’s Resurgence: Regulatory Breakthrough and Supply Shock Fuel Rally

3 hours ago
GoPro Stock

GoPro Shares Retreat as Meme-Storm Rally Meets Competitive Pressure

3 months ago
C3.ai Stock

C3.ai Shares Plummet Following Disappointing Quarterly Report

1 month ago
CRWD stock news

Analyst Bullish on Ciena with Increased Price Target

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Palantir Shares Under Pressure as Executives Liquidate Holdings

Healwell AI Shares: Is the Downtrend Exhausted?

Netflix’s Bold Bid for Warner Bros. Discovery Sends Shockwaves Through Market

Opendoor Shares Navigate Turbulent Trading as New Warrants Debut

IonQ’s Defense Sector Breakthrough and European Expansion

Marvell Technology: Poised for an AI-Driven Breakout?

Trending

Valneva Stock
Earnings

Valneva Stock: Navigating a Critical Juncture

by Andreas Sommer
November 25, 2025
0

Investors in French vaccine developer Valneva are facing a period of intense uncertainty. The company's latest financial...

Apex Critical Metals Stock

Unearthing Value: Apex Critical Metals’ Novel Approach to Rare Earth Exploration

November 25, 2025
Barrick Stock

Barrick Gold Reaches Landmark $430 Million Settlement to Resolve Mali Dispute

November 25, 2025
Palantir Stock

Palantir Shares Under Pressure as Executives Liquidate Holdings

November 25, 2025
Healwell AI Stock

Healwell AI Shares: Is the Downtrend Exhausted?

November 25, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Valneva Stock: Navigating a Critical Juncture
  • Unearthing Value: Apex Critical Metals’ Novel Approach to Rare Earth Exploration
  • Barrick Gold Reaches Landmark $430 Million Settlement to Resolve Mali Dispute

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com